Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
HCC1806 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.052338 | 0.2620 | 0.3895 | 0.0353 | 0.9021 | 0.019916 | 0.9778 |
HCC1806 | PF-4708671 | p70S6K | PI3K/mTOR | Inf | 1.0500 | -0.0207 | -0.0033 | 0.0000 | Inf | -0.67606 |
HCC1806 | Buparlisib | pan PI3K | PI3K/mTOR | 1.0455 | -0.2692 | 0.3051 | 0.1247 | 2.2933 | 1.2847 | 0.99486 |
HCC1806 | Pictilisib | pan PI3K | PI3K/mTOR | 5.8714 | 0.1936 | 0.1178 | 0.0220 | 1.3031 | 13.6419 | 0.96395 |
HCC1806 | Ceritinib | ALK | RTK | 2.1149 | -0.4060 | 0.1766 | 0.0793 | 2.2387 | 2.8712 | 0.99364 |
HCC1806 | Neratinib | EGFR/HER2 | RTK | 0.77903 | -0.0883 | 0.1927 | 0.0757 | 0.8116 | 3.0161 | 0.95894 |
HCC1806 | Tivantinib | MET | RTK | 0.27161 | -0.2185 | 0.4464 | 0.1810 | 3.1555 | 0.30267 | 0.99849 |
HCC1806 | Cediranib | VEGFR/cKIT | RTK | 4.9315 | 0.0954 | 0.0645 | 0.0363 | 4.9998 | 4.7786 | 0.98723 |
HCC1806 | Cabozantinib | VEGFR2/MET | RTK | 11.367 | 0.6905 | -0.0025 | 0.0050 | 4.9955 | 13.3217 | 0.89668 |
Hs 578T | Abemaciclib | CDK4/6 | Cell cycle | 0.077629 | -0.5825 | 0.6343 | 0.1966 | 0.4160 | 1.0889 | 0.95772 |
Hs 578T | Palbociclib | CDK4/6 | Cell cycle | 0.15611 | 0.3049 | 0.3195 | 0.0363 | 0.7223 | 0.037735 | 0.98196 |
Hs 578T | AZD7762 | CHK1/2 | Cell cycle | 0.015096 | -0.5983 | 0.8646 | 0.4133 | 1.8783 | 0.01967 | 0.95944 |
Hs 578T | Volasertib | PLK | Cell cycle | 0.0025675 | -0.3123 | 0.8198 | 0.3337 | 3.0081 | 0.0029864 | 0.9987 |
Hs 578T | Dinaciclib | pan CDK | Cell cycle | 0.0089363 | -0.2388 | 0.6160 | 0.2121 | 4.9934 | 0.0096082 | 0.99916 |
Hs 578T | Cisplatin | Chemo | Chemotherapy | 1.5413 | 0.0125 | 0.2347 | 0.0930 | 1.4392 | 1.6968 | 0.99339 |
Hs 578T | Doxorubicin | Chemo | Chemotherapy | 0.0041078 | -0.3466 | 0.8007 | 0.2450 | 1.2269 | 0.0052684 | 0.96807 |
Hs 578T | Taxol | Chemo | Chemotherapy | 0.0010154 | -0.3752 | 0.9535 | 0.4788 | 1.2811 | 0.0015458 | 0.95438 |
Hs 578T | Topotecan | Topo I | Chemotherapy | 0.0049855 | -0.4488 | 1.0175 | 0.4717 | 1.1814 | 0.0076404 | 0.9429 |
Hs 578T | Etoposide | Topo II | Chemotherapy | 0.41322 | -0.1361 | 0.3770 | 0.1666 | 2.0332 | 0.46109 | 0.99901 |
Hs 578T | Dasatinib | BCR/ABL | MAPK/nRTK | 0.038606 | -0.2442 | 0.7103 | 0.2679 | 0.9749 | 0.059157 | 0.98877 |
Hs 578T | Trametinib | MEK | MAPK/nRTK | 0.0063584 | 0.1931 | 0.4907 | 0.0713 | 0.9022 | 0.0036513 | 0.99154 |
Hs 578T | Saracatinib | SRC | MAPK/nRTK | 4.0375 | 0.1890 | 0.1594 | 0.0291 | 0.7110 | 18.9291 | 0.97543 |
Hs 578T | ABT-737 | Bcl2/XL | Misc | Inf | 0.7755 | 0.0260 | 0.0177 | 1.3421 | 4.2689 | 0.94189 |
Hs 578T | Vorinostat | HDAC | Misc | 0.90288 | -0.1689 | 0.2728 | 0.1049 | 2.2431 | 1.0225 | 0.99568 |
Hs 578T | Luminespib | HSP90 | Misc | 0.0032976 | -0.1144 | 0.6699 | 0.2289 | 2.5765 | 0.0035402 | 0.99828 |